Trials / Recruiting
RecruitingNCT06876610
Application of CfDNA Methylation Detection in Auxiliary Diagnosis of Breast Cancer
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 200 (estimated)
- Sponsor
- Geneplus-Beijing Co. Ltd. · Industry
- Sex
- All
- Age
- 30 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to construct an auxiliary diagnostic model for breast cancer by methylation markers. The study will collect blood and tissue samples from participants with breast cancer and benign disease for whole-genome methylation sequencing. It will screen methylation markers and develop a methylation auxiliary diagnosis model to distinguish between breast cancer and non-cancer.
Conditions
Timeline
- Start date
- 2025-03-15
- Primary completion
- 2026-08-31
- Completion
- 2026-08-31
- First posted
- 2025-03-14
- Last updated
- 2025-03-14
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06876610. Inclusion in this directory is not an endorsement.